Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Carcinoma × Cyclophosphamide × Clear all

Phase

Phase 2 5 Phase 1 4 Phase 1/2 3 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Multiple Myeloma 6 Recurrence 5 Ovarian Neoplasms 4 Neoplasms 4 Burkitt Lymphoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 3 Leukemia, Myeloid, Acute 3 Solid Tumor 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Lymphoma, T-Cell 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uveal Melanoma 1 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Solid Cancer 1 Salivary Gland Neoplasms 1 Renal Insufficiency 1

Interventions

fludarabine 1 aldesleukin 1 adavosertib 1 Oncolytic Virotherapy 1 Interleukin-2 1 Cyclophosphamide 1 Clinical Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05141474 2024-11-07

NEXTGENTIL-ACT

Vall d'Hebron Institute of Oncology

Phase EARLY_PHASE1 Recruiting

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡